1. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019) Authors: Piprot, C; Cals, L; Chaigneau, L; Demarchi, F; N'Guyen, T; Stein, U; Villanueva, C; Bréau, JL; Chouahnia, AK; Saintigny, P; Boué, F; deSaint-Hilaire, P; Guimont, I; Grossat, N; Valenza, B; Lévy, E; Médioni, J; Delbaldo, C; Grenier, J; Pouessel, D Journal: Lancet Issue: Volume 393:Issue 10191(2019) Page Start: 2591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 92PDetection of PIK3CA mutation by circulating DNA during chemotherapy: A tool to identify hard-to-treat metastatic breast cancers. (7th November 2019) Authors: Mosele, F; Lusque, A; Tran Dien, A; Droin, N; Le Tourneau, C; Sablin, M P; Lacroix, L; Miran, I; Jovelet, C; Bieche, I; Soria, J-C; Bertucci, F; Bonnefoi, H; Campone, M; Dalenc, F; Bachelot, T; Jacquet, A; Jimenez, M; André, F Journal: Annals of oncology Issue: Volume 30(2019)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 351PImpact of breast cancer molecular subtypes on the occurrence, kinetics and prognosis of central nervous system metastases in a large multicenter cohort. (23rd October 2018) Authors: Jacot, W; Louvel, G; Darlix, A; Fraisse, J; Brain, E; Debled, M; Mouret Reynier, M A; Goncalves, A; Dalenc, F; Augereau, P; Ferrero, J-M; Levy, C; Fumet, J-D; Jouannaud, C; Veyret, C; Dieras, V; Robain, M; Courtinard, C; Pasquier, D; Bachelot, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 288PDPERNETTA: A non-comparative randomized open label phase II trial of pertuzumab (P) + trastuzumab (T) with or without chemotherapy both followed by T-DM1 in case of progression, in patients with HER2-positive metastatic breast cancer (MBC): (SAKK 22/10 / UNICANCER UC-0140/1207). (23rd October 2018) Authors: Huober, J; Weder, P; Veyret, C; Thürlimann, B; Xyrafas, A; Vanlemmens, L; Guiu, S; Brain, E; Grenier, J; Dalenc, F; Levy, C; Savoye, A M; Müller, A; Membrez-Antonioli, V; Gerard, M A; Lemonnier, J; Hawle, H; Boven, E; Bonnefoi, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Letrozole and palbociclib versus chemotherapy as neoadjuvant therapy of high-risk luminal breast cancer. (11th October 2018) Authors: Cottu, P; D'Hondt, V; Dureau, S; Lerebours, F; Desmoulins, I; Heudel, P -E; Duhoux, F P; Levy, C; Mouret-Reynier, M -A; Dalenc, F; Frenel, J -S; Jouannaud, C; Venat-Bouvet, L; Nguyen, S; Ferrero, J -M; Canon, J -L; Grenier, J; Callens, C; Gentien, D; Lemonnier, J Journal: Annals of oncology Issue: Volume 29:Number 12(2018) Page Start: 2334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 294PD_PRManagement and outcome of metastatic breast cancer in men in the national multicenter observational ESME program. (23rd October 2018) Authors: Sirieix, J; Fraisse, J; Mathoulin-Pelissier, S; Leheurteur, M; Vanlemmens, L; Jouannaud, C; Dieras, V; Levy, C; Dalenc, F; Mouret-Reynier, M-A; Petit, T; Coudert, B; Brain, E; Pistilli, B; Ferrero, J-M; Gonçalves, A; Uwer, L; Gourgou, S; Frenel, J-S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. (8th October 2019) Authors: Ferreira, A R; Di Meglio, A; Pistilli, B; Gbenou, A S; El-Mouhebb, M; Dauchy, S; Charles, C; Joly, F; Everhard, S; Lambertini, M; Coutant, C; Cottu, P; Lerebours, F; Petit, T; Dalenc, F; Rouanet, P; Arnaud, A; Martin, A; Berille, J; Ganz, P A Journal: Annals of oncology Issue: Volume 30:Number 11(2019) Page Start: 1784 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019) Authors: Pivot, Xavier; Romieu, Gilles; Debled, Marc; Pierga, Jean-Yves; Kerbrat, Pierre; Bachelot, Thomas; Lortholary, Alain; Espié, Marc; Fumoleau, Pierre; Serin, Daniel; Jacquin, Jean-Philippe; Jouannaud, Christelle; Rios, Maria; Abadie-Lacourtoisie, Sophie; Venat-Bouvet, Laurence; Cany, Laurent; Catal... Journal: Lancet Issue: Volume 393:Issue 10191(2019) Page Start: 2591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗